Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05724875 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FLASH Radiotherapy for Skin Cancer

Study acronym: LANCE
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 27, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Sep 2026 to May 2026
    • Site details revised
    v6
  2. Eligibility criteria expanded, about 22 wordsv5
  3. Re-verified, no change to tracked fieldsv4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2023 to Jun 22, 2023
    • Site details revised
    v3
  5. Primary endpoints revised (2)
    • Secondary endpoints: details revised at 2 of 11 entries
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single center randomized selected Phase II study of FLASH radiotherapy (RT) versus standard of care (SOC) radiotherapy in patients with localized Cutaneous Squamous Cell Carcinoma (cSCC) or Basal Cell Carcinoma (BCC). In summary, the aims of the study are to describe and compare the toxicity and efficacy of high dose rate radiotherapy (FLASH therapy) to SOC conventional radiotherapy (according to the standard guidelines per lesion size) through a randomized Phase II selection study in patients presenting localized cSCC or BCC requiring a radiotherapy treatment.
Trial Details
NCT Number NCT05724875
Lead Sponsor Centre Hospitalier Universitaire Vaudois
Conditions
(from sponsor)		 Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma
Related terms Basal Cell Carcinoma
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov